Chapter 246 How much does it cost to get technology transfer?
The discovery of special HIV drugs has attracted great attention from the whole world.
With the convening of the press conference, countless people were even more excited and eagerly looking forward to it.
However, some people who are interested were very dissatisfied with Zhang Jianfu's ambiguity about the source of technology when answering reporters' questions.
Of course, this does not affect the authority of the press conference.
With the holding of the press conference, the news that the AIDS special medicine is about to be released has truly spread all over the world.
In addition to the numerous reports on domestic news, many foreign heavyweight media such as the Wall Street Journal, the New York Times, and the Guardian have successively conducted large-scale reports.
【Aids is saved】
【Special AIDS drugs are about to be released】
[The savior of 37.9 million Hiv infected people worldwide is here]
【…】
Within 48 hours after the press conference, more than 300 medical institutions and units in more than 100 countries and regions around the world submitted cooperation applications to Huanyu Bio.
At the same time, relevant Chinese departments also sent people to come for contact and negotiate.
You should know that inventing special HIV drugs in Universal Biologics is not only related to their company, but also involves national interests.
For example, China and the EU signed the China-EU Science and Technology Cooperation Agreement in 1998, which includes medical technology cooperation.
There is no relevant agreement between the United States and Universal Biotechnology cannot be sold to the United States without permission. The United States must come up with some equivalent exchange technology or medical equipment to obtain the right to import special HIV drugs.
Now that the relevant departments come here, in addition to informing relevant rights and obligations, there is another important thing, to accompany the EU Framework Planning Commission to discuss the issue of technical authorization.
At 2 p.m. on the 27th, Block A, Hengfeng Building, Jinhu District.
The spacious and luxurious conference room is full of people. In addition to leaders and entourage from the Ministry of Science and Technology, WHS, the government and other relevant departments, there are also a group of foreigners with high noses and blue eyes.
These people are naturally the commissioners of the EU Framework Planning Commission.
Mainly include Fast, Director-General of the Committee and Lucia, Deputy Commissioner.
"Your Universe Bio is really good."
"Thank you for your praise from the leader. We still have many shortcomings that need to be learned and improved."
"Mr. Zhang, let me introduce you to me, Mr. Fast, Director-General of the European Framework Commission, and Ms. Lucia, Deputy Commissioner."
"Hello, hello~"
"Hello……"
After some greetings, the leaders of China and local governments all laughed and drank tea and chatted. As for specific matters, there were naturally special people to discuss with Huanyu Bio in private, and they did not need to worry about them.
And the people from the EU Framework and Planning Commission have nothing to do with them.
The agreement was signed by the former leader, and the benefits and honors were also taken away by the former. They brought the EU people over here just to fulfill their responsibilities. As for whether the EU people and Universal Bio can negotiate a result, it doesn't matter to them.
Besides, the international situation is changing, and even the UK has left the EU. The agreement signed twenty years ago is now just a superficial one, but in fact it has no binding force on both sides.
Director General Fast, who has gray hair and beautiful beard, pushed the black-framed glasses on the bridge of his nose and said straight to the point: "Mr. Zhang, we are here this time mainly to obtain authorization for the technology and formula of special AIDS drugs."
Of course, Zhang Jianfu knew about the scientific and technological cooperation agreement between China and the EU, so it was no surprise to what Fast said.
He agreed happily: "Yes!"
Director General Fast was surprised. He originally thought that Zhang Jianfu would refuse, but he didn't expect that the other party would agree so readily. He was immediately delighted and his lips began to rise.
But before the smile on Fast's face was fully unfolded, Zhang Jianfu followed closely and said, "But..."
Director General Fast's heart suddenly tightened, he said "Here you come", smiled slightly on his face, and said actively: "President Zhang, please rest assured, we will give some financial compensation."
Zhang Jianfu changed his tone and asked, "How many?"
Fast: "1 million euros."
Zhang Jianfu said funny: "Mr. Fast, as far as I know, the EU's Sixth Framework Program has a annual basic research fund of up to 700 million euros, of which the annual funding for Hiv research is about 30 million euros.
The expenses shall be borne by each EU member state in accordance with the proportion of their respective GDP.
You have digested all the money internally, but we have not provided us with a penny of research funds.
Now, I am giving us 1 million euros like I was sending a beggar, and I want to take away our technical achievements. Do you think it is appropriate?"
Fast's face showed a look of embarrassment, "Uh..."
Deputy Commissioner Lucia, wearing a black skirt and stockings, immediately said: "Mr. Zhang, since you are familiar with the operating rules of our committee, you should know that we are non-profit units, and 1 million euros are compensation, not technology purchases. I hope you understand this."
Zhang Jianfu: "Of course I understand! But the drugs produced are not free, aren't they? Moreover, most of the original drugs imported by my country are at their own expense. Isn't this a fact? So you don't have to tell me any non-profit units, we all know what's going on."
Lucia frowned and said, "But you have to know that China and the EU have signed an agreement, and you must provide us with technical formulas unconditionally."
Zhang Jianfu smiled and said, "Ms. Lucia, if you say that, we have nothing to talk about. Why don't you go back and discuss it?"
Lucia's face looked a little bad, and she frowned and stopped talking.
Fast asked: "Mr. Zhang, can you tell me how much it will cost to get the technology transfer?"
Zhang Jianfu said simply: "We provide 30 million euros of R&D funds every year for three years. In addition, for each drug sold, we have to share the sales of 2,000 euros. How about it? It's not an exaggeration, right?"
Fast: "…"
Lucia: "…"
Isn't this an exaggeration?
It's simply crazy.
Not only does it cost 90 million yuan in authorization fees, but it also costs 2,000 euros in sales, which is so dark that it is endless.
If this is the case, a potion will cost at least 5,000 euros before it can be repaid. How many people can afford it?
Fast stood up and said, "Sorry, let's go first."
Zhang Jianfu stood up and smiled and said, "Okay then! But to be honest, Mr. Fast, the price we offer is already fair."
Fast did not comment.
...
Universal Biologics Laboratory.
In the office, secretary Chu Lin was reporting the results of the negotiation to Zhou Wenhui.
"Mr. Zhang said that the EU may put pressure on us through the government, but he has sent people to communicate in advance, so there is no big problem. Now he is still a little worried about the efficacy of the drug and hopes to start clinical trials as soon as possible."
Zhou Wen smiled and said, "You tell him that you don't need to worry about the efficacy of the medicine! As for the first phase of clinical trial, it will be almost the same in the middle of next month."
"Okay, I understand!" Chu Lin packed up the information and then asked: "Do you have anything to do?"
Zhou Wen flipped through the notepad and said, "It's okay, you go back!"
"Um!"
After Chu Lin left, Zhou Wen stood up and went to the second phase experimental building, the AIDS Research Institute.
In the laboratory, a group of drug research experts were all excited on their faces.
Because the drug has passed the therapeutic experiment, the [drug discovery stage] was directly skipped, that is, the arduous experimental steps such as drug source, chemical synthesis, target screening, and pilot screening, and directly started [preclinical research].
That is, safety evaluation.
Seeing Zhou Wen coming, the person in charge, Dr. Wang Rong, said excitedly: "After preliminary tests, the safety meets the experimental requirements."
Although human trials have been carried out in Bozwana, safety has been guaranteed.
But after all, it is a private experiment. It is impossible to conduct clinical trials without the testing and certification of authoritative institutions.
Now, it's only one step away from clinical trials.
The most important thing is that the result is destined, and this is the most important thing.
Zhou Wen nodded.
After talking to Dr. Wang Rong, I immediately left the AIDS Institute and went to the Anti-Assistance Institute next door.
Chen Ruobing is burying his head in front of the computer to study compounds.
This is the anti-allergic cough she had in the institute before. Zhou Wen discovered the target for her. She also published several papers for this, which was highly recognized by the medical community at home and abroad.
Of course, discovering drug target data does not mean that drugs can be developed, which is not a concept.
Because "compound synthesis" and "screening of active compounds" are also needed later...
Under normal circumstances, the discovery of drug target data is just the first step before the Long March.
Chapter completed!